Eiger BioPharmaceuticals, Inc. 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 14, 2017
Insider Transaction Report
Form 4
WELCH JAMES H
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-03-09+40,000→ 40,000 totalExercise: $11.75Exp: 2027-03-09→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 48 months measured from March 9, 2017 subject to Reporting Person's continuous service status as of each such date.